Home > Publications database > Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation. > print

001     179569
005     20240229145547.0
024 7 _ |a 10.1007/s00134-022-06676-3
|2 doi
024 7 _ |a pmid:35429256
|2 pmid
024 7 _ |a pmc:PMC9012907
|2 pmc
024 7 _ |a 0340-0964
|2 ISSN
024 7 _ |a 0342-4642
|2 ISSN
024 7 _ |a 0935-1701
|2 ISSN
024 7 _ |a 1432-1238
|2 ISSN
024 7 _ |a altmetric:126726932
|2 altmetric
037 _ _ |a DKFZ-2022-00747
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Korell, Felix
|b 0
245 _ _ |a Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.
260 _ _ |a Berlin
|c 2022
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655905601_23455
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:C060# / 2022 Jun;48(6):753-755
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
542 _ _ |i 2022-04-16
|2 Crossref
|u https://creativecommons.org/licenses/by-nc/4.0
542 _ _ |i 2022-04-16
|2 Crossref
|u https://creativecommons.org/licenses/by-nc/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Schreck, Nicholas
|0 P:(DE-He78)0d054b6843ace36d1c965b6cb938d1c9
|b 1
|u dkfz
700 1 _ |a Müller-Tidow, Carsten
|b 2
700 1 _ |a Dreger, Peter
|b 3
700 1 _ |a Luft, Thomas
|0 0000-0002-0387-1640
|b 4
700 1 _ |a Taskforce allogeneic Stem Cell Transplantation, University Hospital Heidelberg
|b 5
|e Collaboration Author
700 1 _ |a Liebregts, Tobias
|b 6
700 1 _ |a Schönland, Stefan
|b 7
700 1 _ |a Hegenbart, Ute
|b 8
700 1 _ |a Radujkovic, Aleksandar
|b 9
700 1 _ |a Schmitt, Michael
|b 10
700 1 _ |a Benner, Axel
|0 P:(DE-He78)e15dfa1260625c69d6690a197392a994
|b 11
|e Last author
|u dkfz
773 1 8 |a 10.1007/s00134-022-06676-3
|b Springer Science and Business Media LLC
|d 2022-04-16
|n 6
|p 753-755
|3 journal-article
|2 Crossref
|t Intensive Care Medicine
|v 48
|y 2022
|x 0342-4642
773 _ _ |a 10.1007/s00134-022-06676-3
|0 PERI:(DE-600)1459201-0
|n 6
|p 753-755
|t Intensive care medicine
|v 48
|y 2022
|x 0342-4642
909 C O |p VDB
|o oai:inrepo02.dkfz.de:179569
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)0d054b6843ace36d1c965b6cb938d1c9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)e15dfa1260625c69d6690a197392a994
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INTENS CARE MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b INTENS CARE MED : 2015
920 2 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1016/S2352-3026(17)30108-4
|9 -- missing cx lookup --
|1 T Luft
|p e414 -
|2 Crossref
|u Luft T, Benner A, Jodele S et al (2017) EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol 4(9):e414–e423
|t Lancet Haematol
|v 4
|y 2017
999 C 5 |a 10.1182/bloodadvances.2021004812
|9 -- missing cx lookup --
|1 M Pena
|p 3418 -
|2 Crossref
|u Pena M, Salas MQ, Mussetti A et al (2021) Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Blood Adv 5(17):3418–3426
|t Blood Adv
|v 5
|y 2021
999 C 5 |a 10.1016/j.bbmt.2020.01.028
|9 -- missing cx lookup --
|1 A Varma
|p 1013 -
|2 Crossref
|u Varma A, Rondon G, Srour SA et al (2020) Endothelial Activation and Stress Index (EASIX) at admission predicts fluid overload in recipients of allogeneic stem cell transplantation. Biol Blood Marrow Transplant 26:1013
|t Biol Blood Marrow Transplant
|v 26
|y 2020
999 C 5 |a 10.3389/fimmu.2021.634416
|9 -- missing cx lookup --
|1 T Luft
|p 634416 -
|2 Crossref
|u Luft T, Wendtner CM, Kosely F et al (2021) EASIX for prediction of outcome in hospitalized SARS-CoV-2 infected patients. Front Immunol 12:634416
|t Front Immunol
|v 12
|y 2021
999 C 5 |a 10.1182/bloodadvances.2020003885
|9 -- missing cx lookup --
|1 M Pennisi
|p 3397 -
|2 Crossref
|u Pennisi M, Sanchez-Escamilla M, Flynn JR et al (2021) Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Adv 5(17):3397–3406
|t Blood Adv
|v 5
|y 2021

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21